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Abstract: In the recentmostmelioidosismeeting inManipal (1st
South Asian Melioidosis Congress) in November, 2015, Dr. David
Dance from University of Oxford told that ‘nearly 165,000 peo-
ple is getting affected with melioidosis every year in the world,
out of which 44% are from South Asian countries’, and further he
added that ‘Indiahas thehighest burden,withmore than50%death,
which are mostly undiagnosed’. It is predicted that Indian subcon-
tinent is presently the ‘hot spot’ of the disease, which has most
number of cases and deaths. After the bacterium was discovered
by the Indian bacteriologist, CS Krishnaswami, in 1912, along with
his physician colleague, A.Whitmore, it took almost 80years (1991)
to diagnose the ﬁrst case of melioidosis in an Indian medical set up
in Mumbai. Since then, only 50 cases have been published in last
25 years, which may merely be considered as the ‘tip of the ice-
berg’. During our last 10 years journey with melioidosis research,
we have performed the ﬁrst extensive seroprevalence study with
29% seropositivity rate, which proved beyond doubt the signiﬁcant
environmental exposure to B. pseudomallei in the soil and water.
Nearly 200 patients withmelioidosis were detected in last 10 years
in our tertiary care hospital predominantly with pneumonia and
highmortality andmostly during heavy rainfall. Our improved lab-
oratory set up help us diagnose cases rapidly and more accurately,
and serve as the reference center for melioidosis in this region.
Humans acquiremelioidosis following contactwith B. pseudomallei
in the environment. We have detected the presence of B. pseu-
domallei while performing soil surveillance in and around Udupi
district with nearly 40% positivity rate. Our clinical isolates are
found to be diverse from Australian and Southeast Asian strains,
suggesting their pure Indian origin more strongly. To strengthen
the melioidosis research in this subcontinent, Indian Melioidosis
Research Forum is formed with scientists and researchers from all
over the world, with a more focused case ﬁnding from eastern and
north-eastern states of India.
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Abstract: Burkholderia pseudomallei, a highly pathogenic bac-
terium that causes melioidosis, is commonly found in soil in
Southeast Asia and Northern Australia. Melioidosis can be difﬁ-
cult to diagnose due to its diverse clinical manifestations and the
inadequacy of conventional bacterial identiﬁcation methods. The
bacteriumis intrinsically resistant toawide rangeof antimicrobials,
and treatment with ineffective antimicrobials may result in case
fatality rates exceeding 70%. The global distribution of B. pseudoma-
llei and burden ofmelioidosis, however, remain poorly understood.
A globally comprehensive database was compiled, comprising
of 22,338 geo-located records of human and animal melioidosis
and presence of environmental B. pseudomallei from reports pub-
lished from 1910 to 2014. We then combined the data in a formal
modelling framework to predict the global distribution of B. pseu-
domallei and estimate the burden of melioidosis.
We estimate there to be 165,000 (95% credible interval 68,000-
412,000) human melioidosis cases per year worldwide, of which
89,000 (36,000-227,000) die. We predict that only 40% of all
melioidosis cases occur in the East Asia and Paciﬁc region, where
